Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder
This study has been completed.
Study NCT00829881 Information provided by National Institute of Mental Health (NIMH)
First Received on January 26, 2009. Last Updated on August 20, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Attention Deficit Disorder with Hyperactivity
Hyperkinesis
More general conditions related to this trial
Attention Deficit and Disruptive Behavior Disorders
Dyskinesias
Mental Disorders
Mental Disorders Diagnosed in Childhood
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Betahistine Hydrochloride
Placebo Capsule
Additional drug interventions recognized in this trial
Betahistine
More general drug interventions related to this trial
Cardiovascular Agents
Histamine Agents
Histamine Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)
Back to top of Main Content
